ProShares Long Online/Short Stores ETF (CLIX)
- Previous Close
40.77 - Open
40.78 - Bid 36.86 x 2200
- Ask 44.68 x 1000
- Day's Range
40.69 - 40.78 - 52 Week Range
29.85 - 42.10 - Volume
1,384 - Avg. Volume
5,669 - Net Assets 10.69M
- NAV 40.80
- PE Ratio (TTM) --
- Yield 0.38%
- YTD Daily Total Return 7.40%
- Beta (5Y Monthly) 0.89
- Expense Ratio (net) 0.65%
The fund invests in financial instruments that ProShare Advisors believes, in combination, should track the performance of the index. The index consists of long positions in the online retailers included in the ProShares Online Retail Index and short positions in the "bricks and mortar" retailers included in the Solactive-ProShares Bricks and Mortar Retail Store Index. The fund is non-diversified.
ProShares
Fund Family
Long-Short Equity
Fund Category
10.69M
Net Assets
2017-11-14
Inception Date
Performance Overview: CLIX
Trailing returns as of 4/17/2024. Category is Long-Short Equity.
People Also Watch
Holdings: CLIX
Top 8 Holdings (60.22% of Total Assets)
Sector Weightings
Related ETF News
Research Reports: CLIX
Analyst Report: CRISPR Therapeutics AG
Crispr Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
RatingBullishPrice TargetENPH: Lowering target price to $116.00
ENPHASE ENERGY INC has an Investment Rating of HOLD; a target price of $116.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingNeutralPrice TargetAnalyst Report: Sunrun Inc.
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed either by Sunrun or by Sunrun’s partners and are owned by the company. Sunrun’s customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.
RatingBullishPrice TargetAnalyst Report: Sunrun Inc.
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed either by Sunrun or by Sunrun’s partners and are owned by the company. Sunrun’s customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.
RatingNeutralPrice Target